Опубликовать статью

Информационное партнерство

Инфоресурсы

Контакты

«

Vol. 20, Art. 11 (pp. 110-133)    |    2019       

»

Substantiation of requirements for perspective technical means of inhalational delivery of medicines for application at the stages of medical evacuation

Ivanov I.M., Nikiforov A.S., Chepur S.V., Djikirba А.V., Pavlova V.S., Sventickaya A.M 1,2

State Scientific Research Testing Institute of the Military Medicine (Lesoparkovaya Str., 4, St. Petersburg, 195043, Russia)
LLC Innovative Pharmaceutical Company "Silver Pharm"

Brief summary

In the review the current level of technical development of individual portable systems for inhalational drug delivery in the form of dry powder is analyzed. In the course of literature analysis it was found that individual portable dry powder inhalers can be considered as promising technical means for application at the stages of medical evacuation. The authors formulated the requirements that must be taken into account when developing convenient and easy-to-use inhalers for provision in structures and departments involved in emergency response.


Key words

medical remedies, inhalation route of administration of drugs, dry powder inhaler, respirable fraction, resistance to breathing

Reference list

1. Varghese V. M, Kumar G.S. Advancements in devices and particle engineering in dry powder inhalation technology // Curr Top Med Chem - 2016. - Vol. 16, ?18. - Rr. 1990-2008.


2. Chrystyn H. The Diskus: a review of its position among dry powder inhaler // Int J Clin Pract. - 2007. - Vol. 61, ?6. - Rr. 1022-1036.


3. Yang M.Y., Chan J.G., Chan H.K. Pulmonary drug delivery by powder aerosols // J Control Release. - 2014. - ? 193. - Pp. 228-240.


4. Kourmatzis A., Cheng S., Chan H.K. Airway geometry, airway flow, and particle measurement methods: implications on pulmonary drug delivery // Expert Opin. Drug Deliv. - 2018. - Vol. 15, ? 3. - Rr. 271-282.


5. Hoppentocht M., Hagedoorn P., Frijlink H.W., de Boer A.H. Technological and practical challenges of dry powder inhalers and formulations. // Adv Drug Deliv Rev. - 2014. -? 75. - Rr. 18-31.


6. Bosnic-Anticevich S.Z. Continued Innovation in Respiratory Care: The Importance of Inhaler Devices // Tuberc Respir Dis (Seoul). - 2018. - Vol. 81, ? 2. - Rr. 91-98.


7. Dekhuijzen P.N., Lavorini F., Usmani O.S. Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(?) or HandiHaler(?) // Patient Prefer Adherence. - 2016. - ? 10. - Rr. 1561-1572.


8. Mehta P. Dry powder inhalers: a focus on advancements in novel drug delivery systems // J Drug Deliv. - 2016. - Rr. 1-17.


9. Rahimpour Y., Kouhsoltani M., Hamishehkar H. Alternative carriers in dry powder inhaler formulations // Drug Discov. Today. - 2014. - Vol. 19, N 5. - Pp. 618-626.


10. Cordts E., Steckel H. Formulation considerations for dry powder inhalers // Ther Deliv. - 2014. - Vol. 5, ? 6. - Rr. 675-689.


11. Lin Y.W., Wong J., Qu L., Chan H.K., Zhou Q.T. Powder production and particle engineering for dry powder inhaler formulations // Curr Pharm Des. - 2015. - Vol. 21, ? 27. - Rr. 3902-3916.


12. Weers J.G., Miller D.P. Formulation design of dry powders for inhalation // J Pharm Sci. - 2015. - Vol. 104, ? 10. - Pp. 3259-3288.


13. TwinCaps, market approved disposable inhaler | Hovione http://www.hovione.com/products-and-services/contract-manufacturing-services/drug-product/inhalation-drug-delivery-device-0


14. Hassan MS, Lau R. Effect of particle formulation on dry powder inhalation efficiency // Curr Pharm Des. - 2010. - ?16 - Rr. 2377-2387.


15. Tong Z., Yu A., Chan H.K., Yang R. Discrete modelling of powder dispersion in dry powder inhalers - a brief review // Curr Pharm Des. - 2015. - Vol. 21, ? 27. - Pp. 3966-3973.


16. Scherließ R, Etschmann C. DPI formulations for high dose applications - Challenges and opportunities. // Int J Pharm. -2018. - Vol. 548, ? 1. - Rr. 49-53.


17. de Boer A.H., Hagedoorn P., Hoppentocht M., Buttini F., Grasmeijer F., Frijlink H.W. Dry powder inhalation: past, present and future // Expert Opin Drug Deliv. - 2017. - Vol. 14, ? 4. - Rr. 499-512.


18. Azouz W., Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice // Prim Care Respir J. - 2012. - ?21. - Rr. 208-213.


19. Lavorini F., Pistolesi M., Usmani O.S. Recent advances in capsule-based dry powder inhaler technology // Multidiscip Respir Med. - 2017. - Vol. 12, ? 11. - Rr. 1-7.


20. Lavorini F, Ninane V, Haughney J, Bjermer L, Molimard M, Dekhuijzen RP. Switching from branded to generic inhaled medications: potential impact on asthma and COPD. Expert Opin Drug Deliv. - 2013. - Vol. 10, ?12. - Rr. 1597-1602.


21. Yadav N., Lohani A. Dry powder inhalers: a review // Indo Global. J. Pharm. Scien. - 2013. - Vol. 3, ? 2. - Pp. 142-155.